As it has been shown previously that tumor-infiltrating NK cells play a critical role in initiating antitumor immunity in response to COX-2 pathway inhibition, we tested whether NK depletion would reduce the therapeutic effect of TPST-1495. The gene discussed is PTGS2; the disease is neoplasm.